| Line Item | 2026-04-30 | Y/Y |
|---|---|---|
| Revenue | $1.74B | +17.3% |
| Cost of Revenue | $416.3M | +9.6% |
| Gross Profit | $1.32B | +19.9% |
| R&D Expense | $451.9M | +23.6% |
| SG&A Expense | $194.4M | +11.0% |
| Operating Income | -$33.5M | +39.0% |
| Interest Expense | $25.1M | -0.7% |
| Pre-tax Income | -$2.3M | +92.7% |
| Income Tax | -$370.1M |
| Line Item | 2026-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $768.7M | +5.7% |
| Short-term Investments | $601.5M | -10.2% |
| Accounts Receivable | $464.4M | +23.6% |
| Current Assets | $2.02B | +4.8% |
| Total Assets | $3.15B | +21.6% |
| Current Liabilities | $1.20B | +19.5% |
| Long-term Debt | $570.9M | +0.2% |
| Line Item | 2026-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $326.9M | +22.8% |
| Capital Expenditures | $5.1M | +17.2% |
| Investing Cash Flow | $26.1M | +122.0% |
| Financing Cash Flow | -$312.3M | -862.6% |
| Free Cash Flow | $321.8M | +22.9% |
| -583.5% |
| Net Income | $367.8M | +440.2% |
| EPS (Basic) | $3.49 | +435.6% |
| EPS (Diluted) | $3.43 | +429.8% |
| Total Liabilities |
| $1.88B |
| +12.6% |
| Stockholders' Equity | $1.28B | +37.7% |